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the previously established correlation patterns, the 
measurement can be considered problematic, and the most 
probable parameter fingerprint can be determined by mixing 
the base fingerprints. 
 
Results: Parameter fingerprints for the most frequent 
energies of Varian and Elekta linacs were generated and used 
to validate BBD. The method is very sensitive to problems 
with depth-dose curves (DDC), e.g. incorrect placement of 
the sensitive volume of the detector, spectral dependencies 
of the detector for large fields/large depths, partial-volume-, 
cable- and scatter-effects. Due to the virtually absent scatter 
in small fields, MC is the ideal method to augment and 
validate the self-consistency of small field dosimetry. The 
precision of error detection is in the range of 0.1 mm 
detector position shifts and 0.3% dose error, for DDC from 
5x5 mm² to 400x400 mm². Output factor variations can be 
detected with a sensitivity of 0.2%, MLC positioning 
uncertainty with a sensitivity of 0.1 mm. Typical issues with 
detector types and accelerator models can be identified. 
 
Conclusion: Monte-Carlo derived phase space abstractions 
can be used to validate the self-consistency and overall 
quality of base data measurements and thereby fill a gap in 
the quality assurance chain. Base data can be validated with 
an accuracy of 0.3%, being one order of magnitude better 
than potential experimental errors. 
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Purpose or Objective: To evaluate the accuracy of the 
CyberKnife Synchrony Respiratory Tracking System (RTS) and 
to validate a method for pre-treatment patient-specific 
delivery quality assurance (DQA). 
 
Material and Methods: An EasyCube Phantom (Sun Nuclear), 
consisting of RW3 slabs, was mounted on the ExacTrac (ET) 
Gating Phantom (Brainlab), which can move along the 
superior-inferior axis of the patient to simulate a moving 
target. Eight fiducial markers were implanted in the 
EasyCube for the treatment set-up and for the tracking. A 
Gafchromic EBT3 film (Ashland) was positioned between two 
slabs of the EasyCube, while a PinPoint ionization chamber 
(PTW) was placed in an appropriate insert. The EBT3 films 
were calibrated with a 6MV beam (Trilogy, Varian) from 0 to 
15 Gy and analysed with the multichannel film dosimetry 
performed by the FilmQA Pro software (Ashland). Our 
evaluation was performed in two steps: 1) the films were 
irradiated with single fields perpendicular to the EasyCube 
for several collimators (3 fixed collimators: 15, 30, 60mm; 3 
IRIS openings: 20, 30 and 40mm) and in different dynamic 
conditions (e.g. motion amplitude of the ET Phantom from 8 
to 28 mm). The delivered and planned dose distributions 
were compared with the gamma (γ) analysis method. The 
local γ passing rates (GP) were evaluated using 3 acceptance 
criteria, varying the local dose difference (LDD), the 
distance-to-agreement (DTA) and the dose threshold (TH): 
3%/3mm TH=10%, 2%/2mm TH=30% and 3%/1mm 
TH=50%.Dynamic cases were also delivered with purposefully 
simulated errors (RTS switched off or low coverage of the 
respiratory correlation model). 2) The DQA plans of 6 clinical 
patients were delivered in different dynamic conditions, for a 
total of 19 cases. The measured and planned dose 
distributions were evaluated with the same γ-index criteria 
of step 1 and the measured PinPoint doses were compared 
with the planned mean doses in the sensitive volume of the 
chamber. 
 
 
The test was considered passed if the 3 γ analysis criteria 
yielded a GP>90% or at least 2 criteria yielded a GP>90% and 
the PinPoint dose difference (ΔD) was <5.0%. 
 
Results: The γ analysis of the collimators showed the need to 
use more γ-index criteria to detect the simulated errors. 
Only the stricter DTA criterion drastically failed the test, 
with GP<70%. All of the DQA plans passed the tests, both in 
static and dynamic conditions. The mean GP (±σ) were 
95.5±5.2% (3%/3mm), 98.6±1.4% (2%/2mm) and 97.8±2.2% 
(3%/1mm).The mean ΔD was 2.9±1.8%. No significant 
differences were found between the static and the dynamic 
cases. 
 
Conclusion: The presented method confirms the ability of 
the RTS, if used properly, to treat a moving target with great 
precision. Our pre-treatment patient-specific DQA method 
was robust, combining PinPoint dose measurements and an 
evaluation of dose distributions with EBT3 films. However, 
we found the need of a detailed study of each case, 
especially when one acceptance criterion does not satisfy the 
tolerance level. 
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Purpose or Objective: Apply a validated Monte Carlo (MC) 
tool for independent dose calculation in proton PBS to 
‘patient specific’ quality assurance (QA) tasks 
 
Material and Methods: We had developedand validated a MC 
tool for independent dose calculation[1]. In this work weuse 
this code for: 
- Recalculationof a clinically approved plan from the TPS, to 
evaluate the quality of our TPSsemi-analytical dose 
calculation algorithm at the level of the individualpatient 
- Recalculationof a treatment session using the Log File 
coming from the Therapy ControlSystem (TCS), to evaluate 
differences in 3D dose distribution in patientanatomy taking 
into account the characteristics of spots (energy, position, 
MUetc.) as actually delivered by the machine 
- Simulationof a 2D patient specific QA (2DQA). 
This is aretrospective study on 10 patients done to evaluate 
the possibility ofsubstituting our actual 2DQA measurement 
process with a completely automatic andreliable MC based 
workflow. For each 2DQA TPS and MC dose 
distributionsrecalculated in water equivalent material, at 
different depths, were comparedwith measurements 
performed with an array of 1020 ionization chambers 
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(IC)detector making use of gamma analysis (3%,3mm): 
measurement and simulationtimes were compared too. 
 
Results: The table shows a comparison of clinically 
significant DVH points from TPS dose distribution, MC 
simulation of the nominal plan and of TCS log file. 
 
 
In figure a comparison of TPS and MC planar dose distribution 
with 2DQA measurements is shown. In our protocol, if the 
passing rate (PR) is above 95% the field is accepted. If it is 
between 95 and 90% a justification must be added to the QA 
report to flag the field as accepted. A passing rate below 90% 
makes the field unacceptable. In the graph 27 fields 
belonging to 10 patients are analysed. MC has a PR always 
greater than 95% for every depth showing a good agreement 
with measurements. TPS results are always in the “grey” area 
between 90 and 95%. The execution time of a 2DQA with an 
array of ICs takes almost 1 hour and half; simulations, that 
can be performed in parallel, take 11 minutes on average. 
 
 
 
Conclusion: We realized a system to verify with an 
independent calculation algorithm both the nominal plan and 
the delivered one with the TPS dose distribution. This lets 
the user to estimate the effects on the dose distribution due 
to a different algorithm and due to delivery uncertainties of 
the machine. We proposed a method to drastically reduce 
2DQA verification time. Our suggestion is to substitute 
measurements with simulation that showed a very high 
accordance in terms of gamma PR (always above 95%); one 
field per patient may be measured at single depth as an 
additional safety check.  
[1] F Fracchiolla et al,'End to end' validation of a Monte Carlo 
code for independent dose calculation in a proton pencil 
beam scanning system Radand Onc, 115, S78–S79, 2015 
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Purpose or Objective: The treatment couches for Gantry2 
will support new head pieces for head and neck treatments, 
the BoS HeadframeTM. Thanks to their geometry and 
composition (a sandwich of thin carbon layers and light 
foam), they will increase the flexibility of planning, as they 
should only minimally disturb proton beams passing through 
it. Therefore there will be no restrictions in the deliverable 
gantry angles; posterior targets will be treated in supine 
position, thus increasing patient comfort, safety (especially 
for children under anesthesia) and the position accuracy (bite 
block will be used more often). We describe here the 
measurement of their Water Equivalent Range (WER) and 
homogeneity. 
 
Material and Methods: Mono-energetic scanned proton layers 
(12x20cm2) of 129 MeV up to 145 MeV were delivered through 
the head support, with the proton dose on exit being 
measured using a scintillating screen/CCD camera device 
approach. A reference set of measurements were first 
performed without the head support with 1 MeV discrete 
energy steps. The measurements were then repeated for 
three different positions (head, neck and shoulder) of the 
head support. A second set of measurements were performed 
with an energy step of 0.2 MeV for energies between 133-139 
MeV, to increase the measurement accuracy. For each 
acquisition, a 2D map of the maximum values among all the 
layers was generated, from which the WER of the head 
support in the different positions could be calculated by 
subtracting the measurements with and without the frame. 
WER homogeneity was calculated as the standard deviation of 
sub-regions of the 2D difference maximum value maps. CT 
images of the head supports were also imported in the TPS 
and converted to WER (via HU-Relative Proton Stopping 
Power calibration curve), to estimate if the planned WER 
corresponded to the measured values (with no need of 
synthetic CTs). 
 
Results: WER was found to be between 2.4mm and 7.2mm 
with an accuracy of 1.0mm or 0.5mm, depending on the 
measurements energy steps (respectively 1.0 MeV and 0.2 
MeV) (Fig). In the three different positions, WER in-
homogeneity was lower than 1.0mm (respectively 0.36mm, 
0.99mm and 0.40mm). The differences of WER between 
measured and TPS values were also below 0.5 mm (0.2 MeV 
step) and 1.4 mm (1 MeV step). 
 
 
 
Conclusion: The described method was accurate, fast and 
reproducible. The results on the thickness and homogeneity 
of the head frame show that it can be safely and accurately 
used in clinical operation and the first patients have already 
been treated. 
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Purpose or Objective: Accurate modeling of the MLC is 
necessary to achieve a clinically acceptable agreement 
between dose calculations and measurements in IMRT/VMAT 
treatment plans. The RayStation TPS uses several parameters 
to model a MLC but no specific procedure exists on how to 
perform measurements to optimize them. The aim of this 
work is to present a fast procedure to optimize the MLC 
parameters in RayStation v.4.5 and to assess the obtained 
MLC model. 
 
Material and Methods: A proper set of MLC-collimated fields 
was designed on a Varian Trilogy linear accelerator equipped 
with a Millennium 120 MLC. Dose profile scans of those fields 
